592 related articles for article (PubMed ID: 27435502)
21. Altered microRNA Expression Profiles and Regulation of INK4A/CDKN2A Tumor Suppressor Genes in Canine Breast Cancer Models.
Lutful Kabir FM; DeInnocentes P; Bird RC
J Cell Biochem; 2015 Dec; 116(12):2956-69. PubMed ID: 26095675
[TBL] [Abstract][Full Text] [Related]
22. Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology (Review).
Gambari R; Brognara E; Spandidos DA; Fabbri E
Int J Oncol; 2016 Jul; 49(1):5-32. PubMed ID: 27175518
[TBL] [Abstract][Full Text] [Related]
23. miRNAs as potential markers for breast cancer and regulators of tumorigenesis and progression (Review).
Mu H; Zhang W; Qiu Y; Tao T; Wu H; Chen Z; Xu G
Int J Oncol; 2021 May; 58(5):. PubMed ID: 33760165
[TBL] [Abstract][Full Text] [Related]
24. Mirna Expression in Bladder Cancer and Their Potential Role in Clinical Practice.
Blanca A; Cheng L; Montironi R; Moch H; Massari F; Fiorentino M; Raspollini MR; Scarpelli M; Lopez-Beltran A
Curr Drug Metab; 2017 Oct; 18(8):712-722. PubMed ID: 28524002
[TBL] [Abstract][Full Text] [Related]
25. The Role of MicroRNAs in Diagnosis, Prognosis, Metastasis and Resistant Cases in Breast Cancer.
Teoh SL; Das S
Curr Pharm Des; 2017; 23(12):1845-1859. PubMed ID: 28231756
[TBL] [Abstract][Full Text] [Related]
26. The clinicopathological significance and drug target potential of FHIT in breast cancer, a meta-analysis and literature review.
Su Y; Wang X; Li J; Xu J; Xu L
Drug Des Devel Ther; 2015; 9():5439-45. PubMed ID: 26491255
[TBL] [Abstract][Full Text] [Related]
27. Implication of microRNAs in drug resistance for designing novel cancer therapy.
Sarkar FH; Li Y; Wang Z; Kong D; Ali S
Drug Resist Updat; 2010 Jun; 13(3):57-66. PubMed ID: 20236855
[TBL] [Abstract][Full Text] [Related]
28. The therapeutic potential of microRNAs in cancer.
Thorsen SB; Obad S; Jensen NF; Stenvang J; Kauppinen S
Cancer J; 2012; 18(3):275-84. PubMed ID: 22647365
[TBL] [Abstract][Full Text] [Related]
29. MicroRNAs in the thyroid.
Boufraqech M; Klubo-Gwiezdzinska J; Kebebew E
Best Pract Res Clin Endocrinol Metab; 2016 Oct; 30(5):603-619. PubMed ID: 27923454
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
[TBL] [Abstract][Full Text] [Related]
31. microRNA expression profiles as decision-making biomarkers in the management of bladder cancer.
Amir S; Mabjeesh NJ
Histol Histopathol; 2017 Feb; 32(2):107-119. PubMed ID: 27586262
[TBL] [Abstract][Full Text] [Related]
32. Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring.
McGuire A; Brown JA; Kerin MJ
Cancer Metastasis Rev; 2015 Mar; 34(1):145-55. PubMed ID: 25721950
[TBL] [Abstract][Full Text] [Related]
33. MicroRNAs as Biomarker for Breast Cancer.
Aggarwal T; Wadhwa R; Gupta R; Paudel KR; Collet T; Chellappan DK; Gupta G; Perumalsamy H; Mehta M; Satija S; Hansbro PM; Dua K; Maurya PK
Endocr Metab Immune Disord Drug Targets; 2020; 20(10):1597-1610. PubMed ID: 32342824
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-based therapy and breast cancer: A comprehensive review of novel therapeutic strategies from diagnosis to treatment.
Kaboli PJ; Rahmat A; Ismail P; Ling KH
Pharmacol Res; 2015 Jul; 97():104-21. PubMed ID: 25958353
[TBL] [Abstract][Full Text] [Related]
35. MicroRNAs as biomarkers for early breast cancer diagnosis, prognosis and therapy prediction.
Nassar FJ; Nasr R; Talhouk R
Pharmacol Ther; 2017 Apr; 172():34-49. PubMed ID: 27916656
[TBL] [Abstract][Full Text] [Related]
36. MicroRNAs in breast cancer: oncogene and tumor suppressors with clinical potential.
Wang W; Luo YP
J Zhejiang Univ Sci B; 2015 Jan; 16(1):18-31. PubMed ID: 25559952
[TBL] [Abstract][Full Text] [Related]
37. The role of microRNAs in bladder cancer.
Enokida H; Yoshino H; Matsushita R; Nakagawa M
Investig Clin Urol; 2016 Jun; 57 Suppl 1(Suppl 1):S60-76. PubMed ID: 27326409
[TBL] [Abstract][Full Text] [Related]
38. Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers.
Hamam R; Hamam D; Alsaleh KA; Kassem M; Zaher W; Alfayez M; Aldahmash A; Alajez NM
Cell Death Dis; 2017 Sep; 8(9):e3045. PubMed ID: 28880270
[TBL] [Abstract][Full Text] [Related]
39. The role of microRNA in resistance to breast cancer therapy.
Robertson NM; Yigit MV
Wiley Interdiscip Rev RNA; 2014; 5(6):823-33. PubMed ID: 25044299
[TBL] [Abstract][Full Text] [Related]
40. New insight into the role of miRNAs in leukemia.
Zhang H; Chen Y
Sci China C Life Sci; 2009 Mar; 52(3):224-31. PubMed ID: 19294347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
